Haiyuan Shen

Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Journal: Seminars in liver disease

Published: April 07, 2026

Bioactive molecule-derived covalent organic frameworks as biocompatible scaffolds for targeted AKR1B10 inhibition in alcoholic liver disease.

Bioactive molecule-derived covalent organic frameworks as biocompatible scaffolds for targeted AKR1B10 inhibition in alcoholic liver disease.

Journal: Biomaterials

Published: March 20, 2026

Epithelial MLCK deficiency alleviates alcohol-associated liver disease via dendritic-Th17 cell axis.

Epithelial MLCK deficiency alleviates alcohol-associated liver disease via dendritic-Th17 cell axis.

Journal: JHEP reports : innovation in hepatology

Published: November 25, 2025

Fusobacterium nucleatum alleviates alcohol-associated liver disease through mannose-mediated elevation of Fbp1 and modulation of gut microbiota.

Fusobacterium nucleatum alleviates alcohol-associated liver disease through mannose-mediated elevation of Fbp1 and modulation of gut microbiota.

Journal: Journal of hepatology

Published: August 21, 2025

Lachnospiraceae bacterium alleviates alcohol-associated liver disease by enhancing N-acetyl-glutamic acid levels and inhibiting ferroptosis through the KEAP1-NRF2 pathway.

Lachnospiraceae bacterium alleviates alcohol-associated liver disease by enhancing N-acetyl-glutamic acid levels and inhibiting ferroptosis through the KEAP1-NRF2 pathway.

Journal: Gut microbes

Published: June 13, 2025

Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease.

Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease.

Journal: Cellular & molecular immunology

Published: March 09, 2025

Mannosylated neutrophil vesicles targeting macrophages alleviate liver inflammation by delivering CRISPR/Cas9 RNPs.

Mannosylated neutrophil vesicles targeting macrophages alleviate liver inflammation by delivering CRISPR/Cas9 RNPs.

Journal: Theranostics

Published: November 28, 2024

Alcohol-induced disruption of hepatic m 6 A modification exacerbates alcohol-associated steatohepatitis by impairing liver immune microenvironment homeostasis.

Alcohol-induced disruption of hepatic m 6 A modification exacerbates alcohol-associated steatohepatitis by impairing liver immune microenvironment homeostasis.

Journal: Hepatology (Baltimore, Md.)

Published: October 31, 2024

Liver diseases: epidemiology, causes, trends and predictions.

Liver diseases: epidemiology, causes, trends and predictions.

Journal: Signal transduction and targeted therapy

Published: June 30, 2024

siRNA-loaded folic acid-modified TPGS alleviate MASH via targeting ER stress sensor XBP1 and reprogramming macrophages.

siRNA-loaded folic acid-modified TPGS alleviate MASH via targeting ER stress sensor XBP1 and reprogramming macrophages.

Journal: International journal of biological sciences

Published: March 08, 2024

The gut microbiota-produced vitamin B6 mitigates alcohol-associated liver disease by attenuating hepatic oxidative stress damage.

The gut microbiota-produced vitamin B6 mitigates alcohol-associated liver disease by attenuating hepatic oxidative stress damage.

Journal: Hepatology communications

Published: March 05, 2024

Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification.

Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification.

Journal: Cell host & microbe

Published: February 03, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026